Cytosolic phospholipase A2 protein as a novel therapeutic target for spinal cord injury

Annals of Neurology

Volumn 75, Issue 5, 2014, Pages 644-658

  Liu, Nai Kui ^a   Deng, Ling Xiao ^a   Zhang, Yi Ping ^b   Lu, Qing Bo ^a   Wang, Xiao Fei ^a   Hu, Jian Guo ^a   Oakes, Eddie ^a   Bonventre, Joseph V ^c   Shields, Christopher B ^b   Xu, Xiao Ming ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Norton Healthcare   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; ARACHIDONYL TRIFLUOROMETHYL KETONE; CALCIMYCIN; CERAMIDE 1 PHOSPHATE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOLIPASE A2; 1,3 BUTADIENE DERIVATIVE; 1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; ENZYME INHIBITOR; NITRILE; PHOSPHOLIPASE A2 GROUP IV;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; C57BL 6 MOUSE; CELL DEATH; CELL LOSS; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; HISTOLOGY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MOTOR DYSFUNCTION; MOUSE; NONHUMAN; OLIGODENDROGLIA; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SPINAL CORD INJURY; SPINAL CORD NERVE CELL; TISSUE INJURY; ANIMAL; C57BL MOUSE; CYTOLOGY; DRUG ANTAGONISM; DRUG DELIVERY SYSTEM; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENE TARGETING; GENETICS; INTRASPINAL DRUG ADMINISTRATION; KNOCKOUT MOUSE; MALE; METHODOLOGY; PATHOLOGY; PILOT STUDY; RAT; SPINAL CORD; SPRAGUE DAWLEY RAT; TRANSGENIC MOUSE;

ANIMALS; BUTADIENES; DRUG DELIVERY SYSTEMS; ENZYME ACTIVATION; ENZYME INHIBITORS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE TARGETING; GROUP IV PHOSPHOLIPASES A2; INJECTIONS, SPINAL; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; NITRILES; PILOT PROJECTS; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD; SPINAL CORD INJURIES;

EID: 84902277551     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.24134     Document Type: Article

References (59)

1. Spinal cord injury facts and figures at a glance. J Spinal Cord Med 2012; 35: 480-481.
2. Rabchevsky AG, Patel SP, Springer JE,. Pharmacological interventions for spinal cord injury: where do we stand? How might we step forward? Pharmacol Ther 2011; 132: 15-29.
3. Young W,. Secondary injury mechanisms in acute spinal cord injury. J Emerg Med 1993; 11 (suppl 1): 13-22.
4. Hall ED, Braughler JM,. Role of lipid peroxidation in post-traumatic spinal cord degeneration: a review. Cent Nerv Syst Trauma 1986; 3: 281-294.
5. Park E, Velumian AA, Fehlings MG,. The role of excitotoxicity in secondary mechanisms of spinal cord injury: a review with an emphasis on the implications for white matter degeneration. J Neurotrauma 2004; 21: 754-774.
6. Buki A, Okonkwo DO, Wang KK, Povlishock JT,. Cytochrome c release and caspase activation in traumatic axonal injury. J Neurosci 2000; 20: 2825-2834.
7. Zhao Z, Liu N, Huang J, et al. Inhibition of cPLA2 activation by Ginkgo biloba extract protects spinal cord neurons from glutamate excitotoxicity and oxidative stress-induced cell death. J Neurochem 2011; 116: 1057-1065.
8. Liu NK, Xu XM,. Phospholipase A2 and its molecular mechanism after spinal cord injury. Mol Neurobiol 2010; 41: 197-205.
9. Titsworth WL, Cheng X, Ke Y, et al. Differential expression of sPLA2 following spinal cord injury and a functional role for sPLA2-IIA in mediating oligodendrocyte death. Glia 2009; 57: 1521-1537.
10. Klein J,. Membrane breakdown in acute and chronic neurodegeneration: focus on choline-containing phospholipids. J Neural Transm 2000; 107: 1027-1063.
11. van Rossum GS, Drummen GP, Verkleij AJ, et al. Activation of cytosolic phospholipase A2 in Her14 fibroblasts by hydrogen peroxide: a p42/44(MAPK)-dependent and phosphorylation-independent mechanism. Biochim Biophys Acta 2004; 1636: 183-195.
12. Titsworth WL, Liu NK, Xu XM,. Role of secretory phospholipase a(2) in CNS inflammation: implications in traumatic spinal cord injury. CNS Neurol Disord Drug Targets 2008; 7: 254-269.
13. Farooqui AA, Yang HC, Rosenberger TA, Horrocks LA,. Phospholipase A2 and its role in brain tissue. J Neurochem 1997; 69: 889-901.
14. Bonventre JV,. Roles of phospholipases A2 in brain cell and tissue injury associated with ischemia and excitotoxicity. J Lipid Mediat Cell Signal 1996; 14: 15-23.
15. Liu NK, Zhang YP, Titsworth WL, et al. A novel role of phospholipase A2 in mediating spinal cord secondary injury. Ann Neurol 2006; 59: 606-619.
16. Liu NK, Zhang YP, Han S, et al. Annexin A1 reduces inflammatory reaction and tissue damage through inhibition of phospholipase A2 activation in adult rats following spinal cord injury. J Neuropathol Exp Neurol 2007; 66: 932-943.
17. Clark JD, Schievella AR, Nalefski EA, Lin LL,. Cytosolic phospholipase A2. J Lipid Mediat Cell Signal 1995; 12: 83-117.
18. Lopez-Vales R, Ghasemlou N, Redensek A, et al. Phospholipase A2 superfamily members play divergent roles after spinal cord injury. FASEB J 2011; 25: 4240-4252.
19. Sapirstein A, Bonventre JV,. Specific physiological roles of cytosolic phospholipase A(2) as defined by gene knockouts. Biochim Biophys Acta 2000; 1488: 139-148.
20. Bonventre JV, Huang Z, Taheri MR, et al. Reduced fertility and postischaemic brain injury in mice deficient in cytosolic phospholipase A2. Nature 1997; 390: 622-625.
21. Khan T, Havey RM, Sayers ST, et al. Animal models of spinal cord contusion injuries. Lab Anim Sci 1999; 49: 161-172.
22. Widenfalk J, Lundstromer K, Jubran M, et al. Neurotrophic factors and receptors in the immature and adult spinal cord after mechanical injury or kainic acid. J Neurosci 2001; 21: 3457-3475.
23. Lasiene J, Shupe L, Perlmutter S, Horner P,. No evidence for chronic demyelination in spared axons after spinal cord injury in a mouse. J Neurosci 2008; 28: 3887-3896.
24. Baker KA, Hagg T,. An adult rat spinal cord contusion model of sensory axon degeneration: the estrus cycle or a preconditioning lesion do not affect outcome. J Neurotrauma 2005; 22: 415-428.
25. Basso DM, Beattie MS, Bresnahan JC,. Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection. Exp Neurol 1996; 139: 244-256.
26. Luchetti S, Beck KD, Galvan MD, et al. Comparison of immunopathology and locomotor recovery in C57BL/6, BUB/BnJ, and NOD-SCID mice after contusion spinal cord injury. J Neurotrauma 2010; 27: 411-421.
27. Engesser-Cesar C, Anderson AJ, Basso DM, et al. Voluntary wheel running improves recovery from a moderate spinal cord injury. J Neurotrauma 2005; 22: 157-171.
28. Liu N, Han S, Lu PH, Xu XM,. Upregulation of annexins I, II, and V after traumatic spinal cord injury in adult rats. J Neurosci Res 2004; 77: 391-401.
29. Kalyvas A, David S,. Cytosolic phospholipase A2 plays a key role in the pathogenesis of multiple sclerosis-like disease. Neuron 2004; 41: 323-335.
30. Basso DM, Fisher LC, Anderson AJ, et al. Basso Mouse Scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains. J Neurotrauma 2006; 23: 635-659.
31. Hill RL, Zhang YP, Burke DA, et al. Anatomical and functional outcomes following a precise, graded, dorsal laceration spinal cord injury in C57BL/6 mice. J Neurotrauma 2009; 26: 1-15.
32. Skou JC, Esmann M,. Preparation of membrane-bound and of solubilized (Na+ + K+)-ATPase from rectal glands of Squalus acanthias. The effect of preparative procedures on purity, specific and molar activity. Biochim Biophys Acta 1979; 567: 436-444.
33. Sweadner KJ,. Purification from brain of an intrinsic membrane protein fraction enriched in (Na+ + K+)-ATPase. Biochim Biophys Acta 1978; 508: 486-499.
34. Esmann M,. ATPase and phosphatase activity of Na+,K+-ATPase: molar and specific activity, protein determination. Methods Enzymol 1988; 156: 105-115.
35. Smani T, Zakharov SI, Leno E, et al. Ca2+-independent phospholipase A2 is a novel determinant of store-operated Ca2+ entry. J Biol Chem 2003; 278: 11909-11915.
36. Kennedy BP, Payette P, Mudgett J, et al. A natural disruption of the secretory group II phospholipase A2 gene in inbred mouse strains. J Biol Chem 1995; 270: 22378-22385.
37. Pettus BJ, Bielawska A, Subramanian P, et al. Ceramide 1-phosphate is a direct activator of cytosolic phospholipase A2. J Biol Chem 2004; 279: 11320-11326.
38. Nakamura H, Wakita S, Suganami A, et al. Modulation of the activity of cytosolic phospholipase A2alpha (cPLA2alpha) by cellular sphingolipids and inhibition of cPLA2alpha by sphingomyelin. J Lipid Res 2010; 51: 720-728.
39. Street IP, Lin HK, Laliberte F, et al. Slow- and tight-binding inhibitors of the 85-kDa human phospholipase A2. Biochemistry 1993; 32: 5935-5940.
40. Trimble LA, Street IP, Perrier H, et al. NMR structural studies of the tight complex between a trifluoromethyl ketone inhibitor and the 85-kDa human phospholipase A2. Biochemistry 1993; 32: 12560-12565.
41. Riendeau D, Guay J, Weech PK, et al. Arachidonyl trifluoromethyl ketone, a potent inhibitor of 85-kDa phospholipase A2, blocks production of arachidonate and 12-hydroxyeicosatetraenoic acid by calcium ionophore-challenged platelets. J Biol Chem 1994; 269: 15619-15624.
42. Ackermann EJ, Conde-Frieboes K, Dennis EA,. Inhibition of macrophage Ca(2+)-independent phospholipase A2 by bromoenol lactone and trifluoromethyl ketones. J Biol Chem 1995; 270: 445-450.
43. Ghomashchi F, Loo R, Balsinde J, et al. Trifluoromethyl ketones and methyl fluorophosphonates as inhibitors of group IV and VI phospholipases A(2): structure-function studies with vesicle, micelle, and membrane assays. Biochim Biophys Acta 1999; 1420: 45-56.
44. Springer JE, Azbill RD, Knapp PE,. Activation of the caspase-3 apoptotic cascade in traumatic spinal cord injury. Nat Med 1999; 5: 943-946.
45. Demediuk P, Saunders RD, Anderson DK, et al. Early membrane lipid changes in laminectomized and traumatized cat spinal cord. Neurochem Pathol 1987; 7: 79-89.
46. Demediuk P, Saunders RD, Anderson DK, et al. Membrane lipid changes in laminectomized and traumatized cat spinal cord. Proc Natl Acad Sci U S A 1985; 82: 7071-7075.
47. Resnick DK, Nguyen P, Cechvala CF,. Regional and temporal changes in prostaglandin E2 and thromboxane B2 concentrations after spinal cord injury. Spine J 2001; 1: 432-436.
48. Demediuk P, Daly MP, Faden AI,. Changes in free fatty acids, phospholipids, and cholesterol following impact injury to the rat spinal cord. J Neurosci Res 1989; 23: 95-106.
49. Liu XZ, Xu XM, Hu R, et al. Neuronal and glial apoptosis after traumatic spinal cord injury. J Neurosci 1997; 17: 5395-5406.
50. Crowe MJ, Bresnahan JC, Shuman SL, et al. Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys. Nat Med 1997; 3: 73-76.
51. Kriem B, Sponne I, Fifre A, et al. Cytosolic phospholipase A2 mediates neuronal apoptosis induced by soluble oligomers of the amyloid-beta peptide. FASEB J 2005; 19: 85-87.
52. Tabuchi S, Uozumi N, Ishii S, et al. Mice deficient in cytosolic phospholipase A2 are less susceptible to cerebral ischemia/reperfusion injury. Acta Neurochir Suppl 2003; 86: 169-172.
53. Marusic S, Leach MW, Pelker JW, et al. Cytosolic phospholipase A2 alpha-deficient mice are resistant to experimental autoimmune encephalomyelitis. J Exp Med 2005; 202: 841-851.
54. Sanchez-Mejia RO, Newman JW, Toh S, et al. Phospholipase A2 reduction ameliorates cognitive deficits in a mouse model of Alzheimer's disease. Nat Neurosci 2008; 11: 1311-1318.
55. Kigerl KA, McGaughy VM, Popovich PG,. Comparative analysis of lesion development and intraspinal inflammation in four strains of mice following spinal contusion injury. J Comp Neurol 2006; 494: 578-594.
56. Inman D, Guth L, Steward O,. Genetic influences on secondary degeneration and wound healing following spinal cord injury in various strains of mice. J Comp Neurol 2002; 451: 225-235.
57. Kipnis J, Yoles E, Schori H, et al. Neuronal survival after CNS insult is determined by a genetically encoded autoimmune response. J Neurosci 2001; 21: 4564-4571.
58. Klivenyi P, Beal MF, Ferrante RJ, et al. Mice deficient in group IV cytosolic phospholipase A2 are resistant to MPTP neurotoxicity. J Neurochem 1998; 71: 2634-2637.
59. Sapirstein A, Bonventre JV,. Phospholipases A2 in ischemic and toxic brain injury. Neurochem Res 2000; 25: 745-753.